The Technical Analyst
Heska Corp [HSKA]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Heska Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $119.99
America/New_York / 12 jun 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 309.55 mill |
| EPS: | -1.920 |
| P/E: | -62.49 |
| Earnings Date: | Aug 07, 2023 |
| SharesOutstanding: | 10.91 mill |
| Avg Daily Volume: | 0.337 mill |
| RATING 2023-06-12 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -62.49 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.28x |
| Company: PE -62.49 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 119.09 - 120.89 ( +/- 0.75%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-06-13 | Davis Stephen L | Sell | 500 | Common Stock |
| 2023-06-13 | Hasenmaier Joachim A. | Sell | 2 004 | Common Stock |
| 2023-06-13 | Eyl Steven M. | Buy | 4 056 | Common Stock |
| 2023-06-13 | Eyl Steven M. | Buy | 33 111 | Common Stock |
| 2022-02-28 | Eyl Steven M. | Buy | 20 000 | Non-Qualified Stock Option (right to buy) |
| INSIDER POWER |
|---|
| -9.00 |
| Last 100 transactions |
| Buy: 575 941 | Sell: 596 011 |
Forecast:
01:40 - $125.75
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $119.99 (0.00% ) |
| Volume | 0.331 mill |
| Avg. Vol. | 0.337 mill |
| % of Avg. Vol | 98.28 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For HSKA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
HSKA
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
Latest Press Releases
2023-05-23 07:20:00 - Press Release
Dalan Animal Health Ships First Honey Bee Vaccine To Tauzer Apiaries, Potentially Protecting 25 Million Bees.
Athens, ga.--(business wire)--dalan animal health, inc. (“dalan”), the biotech company pioneering insect health with the world’s first honey bee vaccine, is proud to announce its first product shipment to a commercial beekeeper. the shipment is for trevor tauzer of tauzer apiaries in california and contains 500 doses, potentially protecting 25 million bees at an average of 50,000 bees per hive. this milestone follows the u.s. department of agriculture (usda) granting a conditional license to dalan's first-in-class honeybee vaccine earlier this year. the vaccine is indicated to protect honeybees against the devastating american foulbrood disease caused by the bacteria paenibacillus larvae...
2023-05-10 20:50:00 - Press Release
Heska Corporation Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Heska Corporation - Hska
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of heska corporation (nasdaqcm: hska) to mars, incorporated. under the terms of the proposed transaction, shareholders of heska will receive $120.00 in cash for each share of heska that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the company. if you believe that this transaction undervalues the company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call ksf managing partner lewis s...
2023-04-04 23:06:00 - Press Release
Heska Corporation Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Heska Corporation - Hska
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of heska corporation (nasdaqcm: hska) to mars, incorporated. under the terms of the proposed transaction, shareholders of heska will receive $120.00 in cash for each share of heska that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the company. if you believe that this transaction undervalues the company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call ksf managing partner lewis s...
2023-04-03 14:13:00 - Press Release
Shareholder Investigation: Halper Sadeh Llc Investigates Hska, Lsi, Exr, Dffn
New york , april 3, 2023 /prnewswire/ -- halper sadeh llc, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: heska corporation (nasdaq: hska)'s sale to mars, incorporated for $120.00 per share. if you are a heska shareholder, click here to learn more about your rights and options.
2023-04-03 10:11:00 - Press Release
Hska Stock Alert: Halper Sadeh Llc Is Investigating Whether The Sale Of Heska Corporation Is Fair To Shareholders
New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the sale of heska corporation (nasdaq: hska) to mars, incorporated for $120.00 per share is fair to heska shareholders. halper sadeh encourages heska shareholders to click here to learn more about their legal rights and options or contact daniel sadeh or zachary halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. the investigation concerns whether heska and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for heska shareholders; (2) determine whether mars is underpaying for heska; and (3) disclose all material information necessary for heska shareholders to adequately assess and value the merger consideration...
Latest News
2023-05-05 10:40:41 - Zacks Investment Research
Heska (HSKA) Q1 Earnings and Revenues Lag Estimates
Heska (HSKA) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.27 per share a year ago.
2023-04-03 11:31:40 - The Motley Fool
Why Heska Stock Is On Fire Today
Heska and privately-held Mars have agreed to a buyout offer of $120 per share. This deal underscores the high-growth potential of pet products companies.
2023-02-28 22:29:11 - Seeking Alpha
Heska Corporation (HSKA) Q4 2022 Earnings Call Transcript
Heska Corporation (NASDAQ:HSKA ) Q4 2022 Earnings Conference Call February 28, 2023 11:00 AM ET Company Participants Jon Aagaard - Investor Relations Kevin Wilson - Chief Executive Officer and President Catherine Grassman - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Erin Wright - Morgan Stanley Ben Haynor - Alliance Global Partners Jim Sidoti - Sidoti & Company Operator Greetings. Welcome to the Heska Corporation Fourth Quarter and Full-Year 2022 Earnings Conference Call.
2023-02-28 12:48:25 - Zacks Investment Research
Heska (HSKA) Q4 Earnings and Revenues Surpass Estimates
Heska (HSKA) delivered earnings and revenue surprises of 44.74% and 3.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
2023-02-13 13:33:16 - Zacks Investment Research
Heska (HSKA) Moves to Buy: Rationale Behind the Upgrade
Heska (HSKA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
2023-01-12 18:30:15 - GuruFocus
Heska Corp's CEO Loads Up on Shares After 70% Nosedive
One of the more unexpected market bubbles that developed from Covid-related easy money policies was the “pet stock” bubble. As people were stuck at home more often, they were more likely to adopt pets and spend more to keep them healthy.
2023-01-11 09:47:24 - Zacks Investment Research
Heska (HSKA) Moves 9.0% Higher: Will This Strength Last?
Heska (HSKA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
2022-11-12 15:37:04 - Seeking Alpha
Heska Corporation (HSKA) Q3 2022 Earnings Call Transcript
Heska Corporation (NASDAQ:HSKA ) Q3 2022 Results Conference Call November 8, 2022 11:00 AM ET Company Participants Jon Aagaard - Director, IR Kevin Wilson - President and CEO Catherine Grassman - EVP and CFO Conference Call Participants Chris Schott - JPMorgan David Westenberg - Piper Semler Elliot Wilbur - Raymond James Ben Haynor - Alliance Global Partners Erin Wright - Morgan Stanley James Sidoti - Sidoti & Company Operator Good day, and welcome to the Heska Corporation Third Quarter 2022 Conference Call. Today's conference is being recorded.
2022-08-08 17:10:19 - Seeking Alpha
Heska Corp (HSKA) CEO Kevin Wilson on Q2 2022 Results - Earnings Call Transcript
Heska Corp (NASDAQ:HSKA ) Q2 2022 Earnings Conference Call August 8, 2022 11:00 AM ET Company Participants Jon Aagaard - Director, IR Kevin Wilson - CEO, President Catherine Grassman - EVP & CFO Conference Call Participants David Westenberg - Piper Sandler Elliot Wilbur - Raymond James Ben Haynor - Alliance Global Partners Erin Wright - Morgan Stanley Jim Sidoti - Sidoti & Company Operator Good day, ladies and gentlemen, and welcome to the Heska Corporation Second Quarter 2022 Conference Call. Today's conference is being recorded.
2022-08-08 09:02:18 - Zacks Investment Research
5 Toxic Stocks That May Prove Hazardous for Your Portfolio
Toxic companies are characterized by huge debt pile and are vulnerable to external shocks. Accurately identifying such stocks and getting rid of them at the right time can protect your portfolio.